Literature DB >> 20921480

A flexible approach to evidentiary standards for comparative effectiveness research.

Louis P Garrison1, Peter J Neumann, Paul Radensky, Sheila D Walcoff.   

Abstract

The Patient Protection and Affordable Care Act established a new Patient-Centered Outcomes Research Institute to identify and address research priorities for comparative effectiveness research. Among its many responsibilities, the institute has been charged with setting priorities, developing methodological standards, and communicating research results to decision makers. In this paper we consider how the institute can support the different standards for acceptable evidence used by various government agencies, providers, patients, and other decision makers. We argue that the public interest will best be served if the institute develops a balanced and flexible approach to deciding which types of studies to fund.

Entities:  

Mesh:

Year:  2010        PMID: 20921480     DOI: 10.1377/hlthaff.2010.0692

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  4 in total

1.  Current and Future Use of HEOR Data in Healthcare Decision-Making in the United States and in Emerging Markets.

Authors:  Anke-Peggy Holtorf; Diana Brixner; Brandon Bellows; Abdulkadir Keskinaslan; Joseph Dye; Gary Oderda
Journal:  Am Health Drug Benefits       Date:  2012-11

2.  Health Economics and Outcomes Research of Wound Care: Overview of Methodology.

Authors:  Adrienne M Gilligan
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-11-12       Impact factor: 4.730

3.  A CTSA agenda to advance methods for comparative effectiveness research.

Authors:  Mark Helfand; Sean Tunis; Evelyn P Whitlock; Stephen G Pauker; Anirban Basu; Jon Chilingerian; Frank E Harrell; David O Meltzer; Victor M Montori; Donald S Shepard; David M Kent
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

4.  Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.

Authors:  Julia R Trosman; Christine B Weldon; R Kate Kelley; Kathryn A Phillips
Journal:  J Natl Compr Canc Netw       Date:  2015-03       Impact factor: 11.908

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.